Results 151 to 160 of about 42,703 (308)

Changing trends in drug overdose mortality in Spain, 2001–2022

Addiction, EarlyView.
Abstract Aim To measure the evolution of drug overdose mortality in Spain between 2001 and 2022. Design, Setting, Participants A repeated cross‐sectional observational study using nationwide mortality data from Spain, 2001–2022, among individuals aged 15–64 years.
Florencia Giné, Marta Donat, Juan Miguel Guerras, Gregorio Barrio, María José Belza, Julieta Politi, Enrique Regidor   +6 more
wiley   +1 more source

Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. [PDF]

, 2019
Purpose: The objectives of this study were to evaluate and compare treatment patterns and infusion-related health care resource expenditures for rheumatoid arthritis (RA) patients initiating golimumab for intravenous use (GLM-IV) and infliximab (IFX ...
DeHoratius, Raphael J., Ellis, Lorie A., Kafka, Shelly, Kubacki, Maureen, Malangone-Monaco, Elisabetta, Stetsovsky, Diana, Varker, Helen   +6 more
core   +1 more source

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed [PDF]

, 2004
L.B.A. van de Putte, Catherine Atkin, Michel Malaise, J Sany, Anthony S. Russell, P L C M van Riel, Loukas Settas, J. W. J. Bijlsma, S Todesco, Maxime Dougados, Peter Nash, Paul Emery, Nike Walter, Martin Kaul, Steven Fischkoff, H. Küpper   +15 more
openalex   +1 more source

IgG4‐Related Disease: Emerging Roles of Novel Genetic Variants, Immune Cell Subsets and Therapeutic Targets

Allergy, EarlyView.
ABSTRACT IgG4, the least abundant IgG subclass in humans, is increasingly recognised for its involvement in allergic and autoimmune pathologies. Its unique properties, such as the tendency to form half‐molecules (one heavy chain and one light chain) and its generally non‐inflammatory nature, distinguish it from other IgG subclasses.
Louisa Tedesco, Syed B. Ali, Baran Erman, Safa Baris, Harshita Pant, Pravin Hissaria, Yelda Bilginer, Damon J. Tumes, Gökhan Cildir   +8 more
wiley   +1 more source

Targeted Therapy for Rheumatoid Arthritis in the New Era

Xiehe Yixue Zazhi
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. The clinical manifestation of RA involves various organs and systems both inside and outside the joints, and often exhibits strong clinical heterogeneity with unclear pathogenesis ...
WANG Jun, MENG Juan
doaj   +1 more source

A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs [PDF]

, 2005
Ernest Choy
openalex   +1 more source

JAK-Inhibitors – A Story of Success and Adverse Events

Open Access Rheumatology: Research and Reviews
Rebekka Wlassits,1 Mathias Müller,2 Karl H Fenzl,1 Thomas Lamprecht,3 Ludwig Erlacher3 1Karl Landsteiner Institut für Autoimmunerkrankungen und Rheumatologie, Vienna, Austria; 2Department für Biomedizinische Wissenschaften, Institut für Tierzucht und ...
Wlassits R, Müller M, Fenzl KH, Lamprecht T, Erlacher L   +4 more
doaj  

Phytochemical Screening and in vivo antioxidant activity of Ethanolic extract of caesalpinia bondus (L.) Roxb [PDF]

, 2012
Phytochemical screening, antioxidant activity in vivo and lipid peroxidation of 75 % ethanolic extract of young twigs and leaves of Caesalpinia bonduc were carried out by chemical test, and assessment of catalase and peroxidase activities and lipid ...
Akindahunsi , A. A, Ntube , C. A, Ogunlana , O. E, Ogunlana , O. O, Olagunju , J. A   +4 more
core   +1 more source

Novel Disease-Modifying Antirheumatic Drugs. I. Synthesis and Antiarthritic Activity of 2-(-4-Methylphenyl)benzothiazoles.

, 1992
Noriyuki Hori, G. TSUKAMOTO, Atsushi Imamura, Masami Ohashi, Tadayuki Saito, Kiyoshi Yoshino   +5 more
openalex   +2 more sources

Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics [PDF]

, 2005
Cheryl Carli, Anna Ehlin, Lars Klareskog, Staffan Lindblad, Scott Montgomery   +4 more
openalex   +1 more source